Picture loading failed.

Anti-IL31 therapeutic antibody (Pre-made Lokivetmab biosimilar,Canine Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Lokivetmab, trade name Cytopoint, is a monoclonal antibody used to treat atopic dermatitis in dogs.[1] It acts against interleukin 31 (IL-31), which is a cytokine involved in causing itchiness (pruritus). Lokivetmab is administered by subcutaneous injection; each dose is effective for four to eight weeks.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-319-1mg 1mg 3090
GMP-Bios-ab-319-10mg 10mg 21890
GMP-Bios-ab-319-100mg 100mg 148000
GMP-Bios-ab-319-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-IL31 therapeutic antibody (Pre-made Lokivetmab biosimilar,Canine Whole mAb)
INN Name Lokivetmab
TargetIL31
FormatCanine Whole mAb
DerivationCaninized
Species ReactivityCanine
CH1 IsotypeIgG2
VD LCKappa
Highest_Clin_Trial (Jan '20)Approved
Est. StatusNFD
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2014
Year Recommended2015
CompaniesZoetis
Conditions ApprovedCanine atopic dermatitis
Conditions Activena
Conditions Discontinuedna
Development Techna